These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17416304)

  • 1. A 21st century HPLC workflow for process R&D.
    Karcher BD; Davies ML; Delaney EJ; Venit JJ
    Clin Lab Med; 2007 Mar; 27(1):93-111. PubMed ID: 17416304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and efficient approach to reversed-phase HPLC method screening.
    Biswas KM; Castle BC; Olsen BA; Risley DS; Skibic MJ; Wright PB
    J Pharm Biomed Anal; 2009 Apr; 49(3):692-701. PubMed ID: 19181471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic stability evaluation of analytical RP-HPLC columns.
    Ye C; Terfloth G; Li Y; Kord A
    J Pharm Biomed Anal; 2009 Oct; 50(3):426-31. PubMed ID: 19540695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid high performance liquid chromatography method development with high prediction accuracy, using 5cm long narrow bore columns packed with sub-2microm particles and Design Space computer modeling.
    Fekete S; Fekete J; Molnár I; Ganzler K
    J Chromatogr A; 2009 Nov; 1216(45):7816-23. PubMed ID: 19815221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving method capability of a drug substance HPLC assay.
    Dejaegher B; Jimidar M; De Smet M; Cockaerts P; Smeyers-Verbeke J; Vander Heyden Y
    J Pharm Biomed Anal; 2006 Sep; 42(2):155-70. PubMed ID: 16621413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of the design and operational considerations of large scale high performance liquid chromatography (HPLC) systems for proteins and peptides purification.
    Wisniewski R
    Bioseparation; 1992; 3(2-3):77-143. PubMed ID: 1369243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New findings in liquid chromatography in the pharmaceutical domain.
    Veuthey JL; Guillarme D; Rudaz S
    Bioanalysis; 2011 Jan; 3(1):5-6. PubMed ID: 21175359
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of high performance liquid chromatographic instrument system on the analysis of erythromycin A oxime].
    Sun JG; Yao GW; Ou YX
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Sep; 24(9):1148-50. PubMed ID: 15762547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of monolithic columns in pharmaceutical analysis. Determination of indomethacin and its degradation products.
    Záková P; Sklenárová H; Nováková L; Hájková R; Matysová L; Solich P
    J Sep Sci; 2009 Aug; 32(15-16):2786-92. PubMed ID: 19603393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient method development strategy for challenging separation of pharmaceutical molecules using advanced chromatographic technologies.
    Xiao KP; Xiong Y; Liu FZ; Rustum AM
    J Chromatogr A; 2007 Sep; 1163(1-2):145-56. PubMed ID: 17628579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
    Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral correlation of high-performance liquid chromatography-diode array detection data from two independent chromatographic runs peak tracking in pharmaceutical impurity profiling.
    Li W; Hu CQ
    J Chromatogr A; 2008 May; 1190(1-2):141-9. PubMed ID: 18374928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in using high performance liquid chromatography for drug analysis.
    Lurie IS
    J Forensic Sci; 1984 Apr; 29(2):607-10. PubMed ID: 6726165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of ultrafast HPLC to process development of recombinant DNA-derived proteins.
    Olson KC; Gehant RL
    Biotechnol Prog; 1992; 8(6):562-6. PubMed ID: 1369039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic evaluation of a coated cellulose tris(3,5-dimethylphenylcarbamate) chiral stationary phase having a small-pore silica support.
    Liu Y; Zou H
    J Chromatogr A; 2008 Jan; 1178(1-2):118-25. PubMed ID: 18068714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs.
    Nageswara Rao R; Nagaraju V
    J Pharm Biomed Anal; 2003 Oct; 33(3):335-77. PubMed ID: 14550856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput screening of active pharmaceutical ingredients by UPLC.
    Al-Sayah MA; Rizos P; Antonucci V; Wu N
    J Sep Sci; 2008 Jul; 31(12):2167-72. PubMed ID: 18563754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of differential scanning calorimetry for the purity verification of pharmaceutical reference standards.
    Mathkar S; Kumar S; Bystol A; Olawoore K; Min D; Markovich R; Rustum A
    J Pharm Biomed Anal; 2009 Apr; 49(3):627-31. PubMed ID: 19186017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.